Gene therapy for the prevention of corneal haze after photorefractive/phototherapeutic keratectomy excimer laser surgery.

Gene therapy for the prevention of corneal haze after photorefractive/phototherapeutic keratectomy excimer laser surgery.
复制标题

用于预防光折射/光疗性角膜切除术准分子激光手术后角膜混浊的基因治疗。

DOI:
--
复制
发表时间:
2002
影响因子:
--
通讯作者:
P. McDonnell
P. McDonnell
中科院分区:
医学4区
文献类型:
--
作者:
A. Behrens;P. McDonnell

文献摘要

参考文献

被引文献

相似文献

十年前,第一个患者成功地使用基因疗法纠正了严重的联合免疫缺陷。从那时起,数百名患者接受了这种疗法,以治疗许多病理情况。然而,在开发临床方案方面进展缓慢,部分原因是缺乏安全和有效的治疗性基因输送系统。
A decade ago the first patient was successfully treated using gene therapy to correct a severe combined immunodeficiency. Since then hundreds of patients have been treated with this therapy for many pathologic conditions. However, progress in developing clinical protocols has been slow, in part due to a lack of safe and efficient delivery systems for the therapeutic genes.
DOI: 10.1001/archopht.1990.01070070051034
发表时间: 1990-05-01
影响因子: --
作者:
FANTES, FE;HANNA, KD;SAVOLDELLI, M
通讯作者: SAVOLDELLI, M
DOI: --
发表时间: 1998-03
影响因子: 4.4
作者:
T. Møller-Pedersen;H. Li;W. Petroll;H. Cavanagh;James V. Jester;James V. Jester
通讯作者: T. Møller-Pedersen;H. Li;W. Petroll;H. Cavanagh;James V. Jester;James V. Jester
逆转录病毒载体介导的基因在体外和体内转移到角膜细胞中。
DOI: 10.1016/s0002-9394(98)00205-0
发表时间: 1998
影响因子: 4.2
作者:
Seitz,B;Moreira,L;Baktanian,E;Sanchez,D;Gray,B;Gordon,EM;Anderson,WF;McDonnell,PJ
通讯作者: McDonnell,PJ
DOI: 10.1016/s0161-6420(00)00142-1
发表时间: 2000-07-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Moller-Pedersen, T;Cavanagh, HD;Jester, JV
通讯作者: Jester, JV
DOI: 10.1089/hum.1997.8.14-1667
发表时间: 1997-09-20
期刊: HUMAN GENE THERAPY
影响因子: 4.2
作者:
Chen, DS;Zhu, NL;Gordon, EM
通讯作者: Gordon, EM